Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies

BACKGROUND: The objective of this post-hoc analysis was to assess the efficacy and safety of upadacitinib in psoriatic arthritis (PsA) patients with axial involvement. METHODS: Post-hoc analysis of SELECT-PsA 1 and SELECT-PsA 2 in patients randomized to upadacitinib 15 mg (UPA15), placebo (switched...

Descripción completa

Detalles Bibliográficos
Autores principales: Baraliakos, Xenofon, Ranza, Roberto, Östör, Andrew, Ciccia, Francesco, Coates, Laura C., Rednic, Simona, Walsh, Jessica A., Douglas, Kevin, Gao, Tianming, Kato, Koji, Song, In-Ho, Ganz, Fabiana, Deodhar, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084601/
https://www.ncbi.nlm.nih.gov/pubmed/37038159
http://dx.doi.org/10.1186/s13075-023-03027-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084601/
https://www.ncbi.nlm.nih.gov/pubmed/37038159
http://dx.doi.org/10.1186/s13075-023-03027-5

Ejemplares similares